ISTA’s Bromday Hearing Request Should Be Deferred Pending Cmte. Review, CDER Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Center for Drug Evaluation and Research tells FDA Commissioner Margaret Hamburg that resource and regulatory policy considerations warrant postponing action on ISTA’s request for a formal evidentiary hearing on its rejected application for a larger fill size.